Dr. Gregory Wirth is a Swiss board-certified (FMH), fellowship-trained urologist and urologic surgeon offering the full spectrum of urological diagnosis and treatment in Geneva, with a focus on innovation, minimally invasive techniques, and attentive patient care.
In 2020, Dr. Wirth joined the Centre d’Urologie Générale-Beaulieu (CUGB), whose founders, Dr. Charles-Henry Rochat and Dr. Georges-Antoine de Boccard, were pioneers of robotic surgery in Switzerland. Building on this heritage, he continues their tradition of excellence while bringing his own experience in urological oncology and academic medicine. Prior to joining CUGB, he served as Vice-Chair in the division of Urology then led by Prof. Christophe Iselin at the Geneva University Hospital (HUG), where he remains a consulting physician.
Raised in an international environment in Strasbourg, France, Dr. Wirth studied medicine at the University of Freiburg, Germany, and completed his specialist training in Switzerland. He subsequently undertook fellowships in urological oncology at Massachusetts General Hospital / Harvard Medical School in Boston (Prof. Aria Olumi) and at Vienna General Hospital (Prof. Shahrokh Shariat) in Austria, deepening his expertise in cancer surgery and academic research.
Dr. Wirth is a member of the Swiss International Prostate Centre (SIPC), a network of renowned specialists in prostate imaging and pathology, as well as in specific treatment modalities for a broad spectrum of prostatic diseases.
He mainly operates at Clinique Générale-Beaulieu, the cradle of robot-assisted urology in Western Switzerland, but regularly works in further hospitals in Geneva and Fribourg, each answering to specific technical needs.
Dr. Wirth serves on the examination board of the Swiss Society of Urology and is a member of the French, the European and the American Associations of Urology. He sits on the board of Cancer Support Switzerland, the English-speaking cancer association in Geneva.